Skip to Main Content
Don't have an account? Create Account
Don't have an account? Create Account

Overcoming COVID-19 Vaccine Hesitancy and Barriers

Date: Wednesday, February 17, 2021

Time: 11:00 AM ET

Although initial demand for COVID-19 vaccines is high, inequitable vaccine distribution and vaccine reluctance among historically marginalized populations may amplify the disease’s disparate outcomes in the hardest-hit communities.

Vaccine hesitancy exists in the general public as well as among health care professionals. Roughly 40 percent of employees at association member Wellforce, in Burlington, Mass., have declined the COVID-19 vaccine. participants explored how Wellforce leverages linguistically and culturally competent physician outreach and community partnerships to respond to the concerns of staff, patients, and the public.


Rosa Colon-Kolacko, PhD, MBA
Vice President and Chief Diversity, Equity, and Inclusion Officer

Jennifer Stephens, MPH
Principal Researcher
America’s Essential Hospitals

Gabriela Andujar Vazquez, MD 
Attending Physician and Assistant Professor
Tufts University School of Medicine

Adam Weston, MD
Medical Director, Antimicrobial Stewardship Program
Lowell General Hospital

Previous Next
Test Caption
Test Description goes like this